about
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cellsDifferential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptorROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer modelsAnthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT.Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeolRole of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer.BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.Castration-resistant prostate cancer: potential targets and therapies.Beneficial effects of tea and its polyphenols against prostate cancer.Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.Tea beverage in chemoprevention and chemotherapy of prostate cancer.Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer.PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts.Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene.Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase.Rescheduling the process of nanoparticle removal used for water mercury remediation can increase the risk to aquatic organism: evidence of innate immune functions modulation in European eel (Anguilla anguilla L.).Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signalingThe S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor.Chemopreventive effect of Vitis vinifera extract on 12-O-tetradecanoyl-13-phorbol acetate-induced cutaneous oxidative stress and tumor promotion in murine skin.Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme.Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.Suppression of thymic lymphomas and increased nonthymic lymphomagenesis in Trp53-deficient mice lacking inducible nitric oxide synthase gene.Attenuation of benzoyl peroxide-mediated cutaneous oxidative stress and hyperproliferative response by the prophylactic treatment of mice with spearmint (Mentha spicata)Evaluation of the efficacy of Lawsonia alba in the alleviation of carbon tetrachloride-induced oxidative stressA novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems
P50
Q26740953-B6276F9E-3D5A-4D50-BAE0-C627C8F62F3DQ28534575-C70F108E-862A-4E40-9527-08024608C8B6Q30009431-D80EF628-2AC7-4FDE-B4C6-590F038CB0EEQ31117251-75FA739F-C692-44EB-BF0B-0F0AAE032026Q33970160-990777EE-B56E-43BE-A7D5-B1AE41383922Q33977990-A4B9E89C-1B81-4681-B0FB-BCD479E751C6Q34180283-C135CA50-EEFB-4506-976D-589519089D9EQ34247788-02268129-2041-4DE0-94C8-D8082FB58D8AQ34544617-91C12BE6-47CA-49CA-B8DF-48235661D054Q34720367-A5267505-9517-49C8-8CFF-265090B01663Q35075493-70BC108E-FC4B-4A0B-8941-174A4A87A10FQ35180333-42C03E2C-E5B4-4502-91D4-446F4A67AE6EQ36196682-F2E498B1-D72E-4AE3-A338-7F852013C116Q36373233-D7213AF4-99B3-4F65-BE9A-CE59CCAE24B9Q36410856-0FAD03EA-28B6-4B33-9DD7-9889E6B03FEAQ36920776-FFC67D92-D9F5-4502-90CE-E581929B8874Q37008469-A7F27B96-B7A1-41C6-9FC5-EE646F057E6AQ37327639-C9F2422F-BBBA-47AB-902D-ED8214FA4136Q37394206-71BE3712-1CBD-4AFE-92C2-E8B5E1A0624DQ38351517-2E44AE4A-9FDC-413C-B10B-81A7FBCAD59AQ39516408-988EE86E-1557-4FF5-9302-2118B3CA0572Q39996106-44293AA1-45B3-4C9E-8F45-2834EC67159FQ40164519-9BBF69D8-9532-42C0-A208-F98038325E2FQ40285122-C9787E9F-8FE0-4D9A-817F-2465BA4A9292Q41332590-B0C63F6A-97CE-40A1-B270-887F3E93570BQ41827126-29B65630-AD3A-4B21-BF33-B86B5C7D8A51Q42969892-1A5FCCA3-29BE-4466-AA56-8A34825FE615Q44233284-BF15FD0E-67B4-415C-8EC2-2A0674BC4093Q44758055-B4350833-936C-4DE1-9FB5-3C6D9CD6EE8EQ46548978-C8406501-D89C-4521-9697-3A0E55386C02Q53197134-D3DACB87-9A65-460F-8E09-7FD6C765B697Q54706600-93CD47F7-5A3F-4048-84BA-7861D7447FCCQ73096198-7E80191A-B3AF-4FC0-A0C6-08C809537FD2Q73476960-859EC3B9-691A-4A37-9C2B-D43C8157A268Q91937664-AD3EBA95-0E74-4E55-81C4-F44F7ECA6A32
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7422-7967
@en
name
Mohammad Saleem
@ast
Mohammad Saleem
@en
Mohammad Saleem
@es
Mohammad Saleem
@nl
type
label
Mohammad Saleem
@ast
Mohammad Saleem
@en
Mohammad Saleem
@es
Mohammad Saleem
@nl
prefLabel
Mohammad Saleem
@ast
Mohammad Saleem
@en
Mohammad Saleem
@es
Mohammad Saleem
@nl
P108
P106
P108
P1153
55029388800
P31
P496
0000-0002-7422-7967